pluri-biotech.com (PLUR) - מקדם חוב לטווח ארוך להון

A strong team of Israeli placental technology scientists provides the intellectual potential of Pluri Inc. (PLUR). The ratio of long-term loans to equity visualizes the financial dynamics, where the value 0.00 captures the metric level. The business foundation is a modern plant in Israel with an autonomous power supply. However, the lack of recurring revenue due to a focus on clinical trials makes the company dependent on external financing.

A fundamental stress test of assets requires an assessment of the financing structure's resilience. Pluri Inc. is currently undergoing a business transformation phase as it develops sales markets for cellular technologies. The long-term debt-to-equity ratio determines the degree of financial leverage and dependence on creditors. By analyzing changes in long-term debt relative to equity, an investor can see the balance between borrowed capital and internal reserves. A low debt load confirms the business's safety during the current period of losses.